Sign in to view content

An Analysis of Particle Contamination and Protein Aggregation From Syringes Used for Intravitreal Injection

Jason Noble, MD, FRCSC

Video
Published 2021

Related

New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2022
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Toxicity: RELIEF Trial Results
Karen M Wai, MD
STEPHEN J SMITH, MD
Updates from the Field
2025
Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2020

Category: Instrumentation and Devices

See more